PREX1 and myalgic encephalomeyelitis/chronic fatigue syndrome: These findings add useful information about the biological functions of P-Rex1 in CFs activation and subsequent cardiac fibrosis and suggested that modulation of P-Rex1 could be a potential pharmacological development target.